Boucher Brent J. 4
4 · ANGIODYNAMICS INC · Filed Jul 19, 2019
Insider Transaction Report
Form 4
Boucher Brent J.
SVP and GM of Oncology
Transactions
- Award
Common Stock
2019-07-17+3,226→ 16,769 total - Award
Non-Qualified Stock Option (right to buy)
2019-07-17+10,790→ 10,790 totalExercise: $21.54From: 2020-07-17Exp: 2029-07-17→ Common Stock (10,790 underlying)
Footnotes (2)
- [F1]This acquisition of 3,226 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 3,226 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal installments beginning on July 17, 2020, such that 25% of the restricted stock units will vest on each of July 17, 2020, 2021, 2022 and 2023.
- [F2]These stock options vest in four equal annual installments beginning on July 17, 2020, such that 25% of the options will vest on each of July 17, 2020, 2021, 2022 and 2023.